Leukemia and Lymphoma

New research from Cardinal Health Specialty Solutions has surprising findings about oncologists from meeting MACRA requirements to burnout.

Ways to help lessen the stress that can come with cancer treatments.

A study from Doximity has shocking statistics about oncologist shortages in the U.S. Here’s how you should react.

A Managed Healthcare Executive’s cancer management survey revealed support for the selected use of complementary and alternative medicine. Where do things stand in what some consider a promising treatment area?

As immunotherapy breaks through in cancer therapy, here are five things to know about this promising treatment.

These 10 states have the worst cancer rates in the entire country.

As drug costs continue to increase at an unsustainable rate, some hospitals are finding new solutions.

More affordable, more collaborative, and more personalized care is our cancer care challenge. Here’s how we get there.

This revolutionary therapy raises serious financial questions. Here’s how much it costs, and how payers are responding.

The places where cancer mortality rates are the highest.

Because the mutational burden and the genetic characteristics of children are different from adults, pediatric cancer should be diagnosed and treated differently. Here’s how.

One expert shares three things providers can do to improve their performance in the OCM program.

How Froedtert Hospital achieves success with a 24/7/365 cancer clinic.

Dealing with cancer is challenging enough for patients and providers. But even when their different perspectives are factored in, that’s not the whole story.

A Wamberg Genomic Advisors’ Cancer Survey has revealing findings from people dealing directly with cancer.

As lymphoma treatments become less cookie-cutter and more custom, the Leukemia & Lymphoma Society Chief Medical Officer Gwen Nichols, MD, shares how healthcare executives need to alter their approach to managing therapy regimens to increase cure rates and survivorship.

The ability of an oncology practice to succeed in the OCM varies depending on this key factor, according to Avalere research.

New cancer drugs continue to offer patients hope. Here are eight of them.

This year has been another year full of oncology approvals, proving that the oncology pipeline is robust with first-of-the kind molecules, competitor products for existing agents, and biosimilars.

Cancer comes in different varieties and with different rates of occurrence. Test yourself on these facts about blood cancers.

What these healthcare industry disruptors are, and how they could impact cost and quality of care.

Ochsner Health System’s brings early-stage clinical trials to the Gulf South region.

Home-based palliative care helps ACOs manage fast-growing senior population with a serious or advanced illness, provide quality care, and generate cost savings that enable ongoing participation in the Medicare Shared Savings Program.

FDA issued a recall of popular blood pressure drugs. Here’s what you need to know.

Payers struggle to determine the appropriate criteria for covering innovative treatments and providers want to increase patient access. Patients’ lives can hang in the balance.